A+ A A- Skip to main content

Asian Paints

2169 -56.80

Cipla

1192.4 -3.50

Eicher Motors

6649.5 -176.00

Nestle India

1191.3 10.50

Grasim Inds

2564.1 -28.70

Hindalco Inds.

916.25 11.65

Hind. Unilever

2065.3 0.60

ITC

292.85 1.15

Trent

3550.6 24.10

Larsen & Toubro

3613.1 5.60

M & M

3011.7 -19.80

Reliance Industries

1350.5 -18.70

Tata Consumer

1042 18.20

Tata Motors PVeh

303.3 0.35

Tata Steel

194.14 -0.46

Wipro

194.91 3.73

Apollo Hospitals

7317.5 12.00

Dr Reddy's Labs

1217.3 7.70

Titan Company

4097.2 31.70

SBI

1018.4 0.60

Shriram Finance

891.6 -8.95

Bharat Electron

421.6 2.90

Kotak Mah. Bank

358 1.95

Infosys

1300.8 25.10

Bajaj Finance

826.85 9.55

Adani Enterp.

1834.2 -8.30

Sun Pharma.Inds.

1693.6 -34.90

JSW Steel

1141.3 0.90

HDFC Bank

750.9 8.65

TCS

2450.7 42.50

ICICI Bank

1215.8 3.10

Power Grid Corpn

289.95 -2.85

Maruti Suzuki

12631 122.00

Axis Bank

1197.9 4.80

HCL Technologies

1402.2 47.80

O N G C

287.2 -0.85

NTPC

359.65 -5.00

Coal India

449.35 -0.05

Bharti Airtel

1789.7 7.80

Tech Mahindra

1441.5 37.00

Jio Financial

229.48 -2.45

Adani Ports

1377.6 -7.80

HDFC Life Insur.

566.1 -6.85

SBI Life Insuran

1774 -16.50

Max Healthcare

944.6 -14.30

UltraTech Cem.

10620 -94.00

Bajaj Auto

8758.5 -137.00

Bajaj Finserv

1640.7 -6.30

Interglobe Aviat

4193.5 12.70

Eternal

231.72 -4.80

Corporate News - Detailed News Back
Emcure Pharmaceuticals reduces prices of its weight management drug Poviztra' in India
02-Apr-26   17:46 Hrs IST

Emcure Pharmaceuticals has announced the price revision of its weight management drug Poviztra' (semaglutide injection) across India.

The reduced price would be starting at Rs. 3,999/- per month (4 weekly doses).

The innovator Semaglutide is available in a once-weekly pen device in five strengths of 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg and a maintenance dose of 2.4 mg. It comes in a state-of-the-art pen device that provides the convenience of simple administration and precise dosing.

As the first Indian company to exclusively distribute and commercialise Poviztra', a second brand of Novo Nordisk's semaglutide injection for obesity, Emcure aims to expand access and enable more patients to benefit from this proven therapy at the revised price.


DJIA 46577.55
215.03 0.46%
S&P 500 6594.89
45.37 0.69%
HANG SENG 25116.54
-177.50 -0.70%
NIKKEI 225 52384.74
-1354.94 -2.52%
FTSE 100 10436.29
71.50 0.69%
NIFTY 22713.10
33.70 0.15%
×
Ask Your Question
close
refresh